STAT1 negatively regulates hepatocellular carcinoma cell proliferation

Chen,Guofu; Wang,Haihe; Xie,Shuli; Ma,Jian; Wang,Guangyi

doi:10.3892/or.2013.2398

STAT1 negatively regulates hepatocellular carcinoma cell proliferation

Authors:
- Guofu Chen
- Haihe Wang
- Shuli Xie
- Jian Ma
- Guangyi Wang
View Affiliations

Affiliations: Department of General Surgery, the First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China, Department of Pathogenobiology, Daqing Branch of Harbin Medical University, Daqing 163319, P.R. China
Published online on: April 9, 2013 https://doi.org/10.3892/or.2013.2398
Pages: 2303-2310

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Signal transducer and activator of transcription 1 (STAT1) regulates cell proliferation and survival. The present study aimed to investigate the role of STAT1 in the development and progression of human hepatocellular carcinoma (HCC). The levels of STAT1 expression in 36 HCC and 12 non-HCC liver tissues were examined by immunohistochemistry. The effect of STAT1 overexpression or silencing on the proliferation and apoptosis of HCC cells was determined by MTT and flow cytometric assays. The effect of STAT1 overexpression or silencing on the levels of p53 and cyclin E expression was determined by quantitative PCR and western blot assays. The level of STAT1 expression in the HCC tissues was significantly lower compared to the level in the non-HCC liver tissues and was negatively associated with the histological grade of HCC and serum HBsAg, anti-HCV and α-fetoprotein positivity in HCC patients. Induction of STAT1 overexpression significantly inhibited HepG2 cell proliferation and enhanced HCC cell apoptosis, accompanied by upregulation of p53 expression and STAT1 phosphorylation, but a reduction in cyclin E expression in HepG2 cells. In contrast, knockdown of STAT1 by introduction of STAT1-specific siRNA promoted HepG2 cell proliferation, but inhibited HCC cell apoptosis, accompanied by significant downregulation of p53 expression, but enhancement of cyclin E expression in vitro. Our data suggest that STAT1 may inhibit HCC growth by regulating p53-related cell cycling and apoptosis.

View Figures

View References

1	Farazi PA and DePinho RA: Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 6:674–687. 2006. View Article : Google Scholar : PubMed/NCBI
2	Llovet JM and Bruix J: Molecular targeted therapies in hepatocellular carcinoma. Hepatology. 48:1312–1327. 2008. View Article : Google Scholar : PubMed/NCBI
3	Lodige I, Marg A, Wiesner B, Malecova B, Oelgeschlager T and Vinkemeier U: Nuclear export determines the cytokine sensitivity of STAT transcription factors. J Biol Chem. 280:43087–43099. 2005. View Article : Google Scholar : PubMed/NCBI
4	Mowen K and David M: Regulation of STAT1 nuclear export by Jak1. Mol Cell Biol. 20:7273–7281. 2000. View Article : Google Scholar : PubMed/NCBI
5	Khodarev NN, Minn AJ, Efimova EV, et al: Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells. Cancer Res. 67:9214–9220. 2007. View Article : Google Scholar : PubMed/NCBI
6	Bromberg JF, Horvath CM, Wen Z, Schreiber RD and Darnell JE Jr: Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon α and interferon γ. Proc Natl Acad Sci USA. 93:7673–7678. 1996.PubMed/NCBI
7	Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ and Schreiber RD: IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature. 410:1107–1111. 2001.
8	Osna NA, Clemens DL and Donohue TM Jr: Ethanol metabolism alters interferon gamma signaling in recombinant HepG2 cells. Hepatology. 42:1109–1117. 2005. View Article : Google Scholar : PubMed/NCBI
9	Lin W, Choe WH, Hiasa Y, Kamegaya Y, Blackard JT, Schmidt EV and Chung RT: Hepatitis C virus expression suppresses interferon signaling by degrading STAT1. Gastroenterology. 128:1034–1041. 2005. View Article : Google Scholar : PubMed/NCBI
10	Bromberg J and Darnell JE Jr: The role of STATs in transcriptional control and their impact on cellular function. Oncogene. 19:2468–2473. 2000. View Article : Google Scholar : PubMed/NCBI
11	Yu H and Jove R: The STATs of cancer - new molecular targets come of age. Nat Rev Cancer. 4:97–105. 2004. View Article : Google Scholar : PubMed/NCBI
12	Levy DE and Darnell JE Jr: Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 3:651–662. 2002. View Article : Google Scholar : PubMed/NCBI
13	Samuel CE: Antiviral actions of interferons. Clin Microbiol Rev. 14:778–809. 2001. View Article : Google Scholar : PubMed/NCBI
14	Balasubramanian A, Ganju RK and Groopman JE: Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes. J Infect Dis. 194:670–681. 2006. View Article : Google Scholar : PubMed/NCBI
15	Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, Silverman RH and Borden EC: Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis. 8:237–249. 2003. View Article : Google Scholar : PubMed/NCBI
16	Xi S, Dyer KF, Kimak M, et al: Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis. J Natl Cancer Inst. 98:181–189. 2006. View Article : Google Scholar : PubMed/NCBI
17	Calvisi DF, Ladu S, Gorden A, et al: Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology. 130:1117–1128. 2006. View Article : Google Scholar : PubMed/NCBI
18	Lee CK, Smith E, Gimeno R, Gertner R and Levy DE: STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-γ. J Immunol. 164:1286–1292. 2000.PubMed/NCBI
19	Nguyen H, Lin R and Hiscott J: Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins. Oncogene. 15:1425–1435. 1997. View Article : Google Scholar : PubMed/NCBI
20	Sironi JJ and Ouchi T: STAT1-induced apoptosis is mediated by caspases 2, 3, and 7. J Biol Chem. 279:4066–4074. 2004. View Article : Google Scholar : PubMed/NCBI
21	Knoblich JA, Sauer K, Jones L, Richardson H, Saint R and Lehner CF: Cyclin E controls S phase progression and its down-regulation during Drosophila embryogenesis is required for the arrest of cell proliferation. Cell. 77:107–120. 1994. View Article : Google Scholar : PubMed/NCBI
22	Kortylewski M, Komyod W, Kauffmann ME, Bosserhoff A, Heinrich PC and Behrmann I: Interferon-γ-mediated growth regulation of melanoma cells: involvement of STAT1-dependent and STAT1-independent signals. J Invest Dermatol. 122:414–422. 2004.
23	Bressac B, Galvin KM, Liang TJ, Isselbacher KJ, Wands JR and Ozturk M: Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci USA. 87:1973–1977. 1990. View Article : Google Scholar : PubMed/NCBI
24	Sheahan S, Bellamy CO, Dunbar DR, Harrison DJ and Prost S: Deficiency of G1 regulators P53, P21^Cip1 and/or pRb decreases hepatocyte sensitivity to TGFβ cell cycle arrest. BMC Cancer. 7:2152007.PubMed/NCBI